Amber Salzman
AS
Amber Salzman
CEO & Director
Rate
About
Dr. Amber Salzman is the CEO & Director of Epic Bio, a gene editing startup focused on modulating gene expression at the epigenome level. She has over three decades of experience in the pharmaceuticals industry, having previously served as President and CEO of Ohana Biosciences, Adverum Biotechnologies, and Annapurna, SAS. Dr. Salzman also leads the Stop ALD Foundation, a non-profit medical research foundation dedicated to developing gene therapies for adrenoleukodystrophy (ALD).
Frequently asked
Who is Amber Salzman?
Dr. Amber Salzman is the CEO & Director of Epic Bio, a gene editing startup focused on modulating gene expression at the epigenome level. She has over three decades of experience in the pharmaceuticals industry, having previously served as President and CEO of Ohana Biosciences, Adverum Biotechnologies, and Annapurna, SAS. Dr. Salzman also leads the Stop ALD Foundation, a non-profit medical resear…
What is Amber Salzman's current role?
Amber Salzman is currently CEO & Director.
Comments
No comments yet. Be the first to share your take.
Profile
About Amber Salzman
Amber Salzman is CEO & Director. This profile tracks their companies, funding activity, and news mentions across the AI ecosystem.